$178 Million is the total value of HealthInvest Partners AB's 19 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| V107SC | Buy | WellPoint Inc | $15,690,000 | +38.5% | 145,800 | +28.1% | 8.83% | +9.4% |
| THOR | Buy | Thoratec Corp | $15,351,000 | +179.5% | 440,366 | +187.1% | 8.64% | +120.8% |
| MGLN | Buy | Magellan Health Inc | $15,074,000 | +80.9% | 242,192 | +72.5% | 8.49% | +43.0% |
| CRL | Buy | Charles Riv Labs Intl Inc | $14,879,000 | +14.7% | 278,013 | +29.3% | 8.38% | -9.4% |
| AIQ | Buy | Alliance HealthCare Srvcs In | $13,240,000 | +6.1% | 490,378 | +31.7% | 7.46% | -16.2% |
| AET | Buy | Aetna Inc New | $10,654,000 | +28.1% | 131,400 | +18.5% | 6.00% | +1.2% |
| LPNT | Buy | LifePoint Hospitals Inc | $10,315,000 | +20.7% | 166,100 | +6.0% | 5.81% | -4.7% |
| MDT | Sell | Medtronic Inc | $10,195,000 | -12.0% | 159,900 | -15.0% | 5.74% | -30.5% |
| HRC | Buy | Hill Rom Hldgs Inc | $9,929,000 | +15.9% | 239,200 | +7.7% | 5.59% | -8.4% |
| GILD | New | Gilead Sciences Inc | $9,825,000 | – | 118,500 | +100.0% | 5.53% | – |
| CFN | Buy | CareFusion Corp | $9,739,000 | +15.5% | 219,600 | +4.8% | 5.48% | -8.7% |
| CAH | Buy | Cardinal Health Inc | $9,304,000 | +12.0% | 135,700 | +14.3% | 5.24% | -11.5% |
| HOLX | Sell | Hologic Inc | $8,161,000 | -31.8% | 321,920 | -42.2% | 4.60% | -46.2% |
| ESRX | Express Scripts Hldg Co | $7,453,000 | -7.7% | 107,500 | 0.0% | 4.20% | -27.1% | |
| SKH | Buy | Skilled Healthcare Group Inccl a | $7,000,000 | +45.1% | 1,112,885 | +21.6% | 3.94% | +14.6% |
| GTS | Triple-S Mgmt Corpcl b | $6,359,000 | +11.1% | 354,675 | 0.0% | 3.58% | -12.2% | |
| CRY | Sell | CryoLife Inc | $3,700,000 | -21.2% | 413,364 | -12.3% | 2.08% | -37.8% |
| BASI | New | Bioanalytical Sys Inc | $392,000 | – | 155,097 | +100.0% | 0.22% | – |
| ICCC | Sell | ImmuCell Corp | $345,000 | -11.3% | 78,477 | -3.1% | 0.19% | -30.0% |
| CEMI | Exit | Chembio Diagnostics Inc | $0 | – | -83,372 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-07-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.